These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 1370169)
1. Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins. Russo DM; Turco SJ; Burns JM; Reed SG J Immunol; 1992 Jan; 148(1):202-7. PubMed ID: 1370169 [TBL] [Abstract][Full Text] [Related]
2. The Leishmania donovani lipophosphoglycan T lymphocyte-reactive component is a tightly associated protein complex. Jardim A; Tolson DL; Turco SJ; Pearson TW; Olafson RW J Immunol; 1991 Nov; 147(10):3538-44. PubMed ID: 1940354 [TBL] [Abstract][Full Text] [Related]
3. Characterization of T cell responses to purified leishmania antigens in subjects infected with Leishmania chagasi. Vinhas V; Freire M; Bacellar O; Cunha S; Rocha H; Carvalho EM Braz J Med Biol Res; 1994 May; 27(5):1199-205. PubMed ID: 8000341 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the human T cell responsiveness to purified antigens of Leishmania: lipophosphoglycan (LPG) and glycoprotein 63 (gp 63). Mendonça SC; Russell DG; Coutinho SG Clin Exp Immunol; 1991 Mar; 83(3):472-8. PubMed ID: 2004486 [TBL] [Abstract][Full Text] [Related]
5. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages. Prina E; Lang T; Glaichenhaus N; Antoine JC J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803 [TBL] [Abstract][Full Text] [Related]
6. Leishmania major: Reactive oxygen species and interferon gamma induction by soluble lipophosphoglycan of stationary phase promastigotes. Kavoosi G; Ardestani SK; Kariminia A; Abolhassani M; Turco SJ Exp Parasitol; 2006 Dec; 114(4):323-8. PubMed ID: 16759653 [TBL] [Abstract][Full Text] [Related]
7. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure. Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764 [TBL] [Abstract][Full Text] [Related]
8. Parasite escape mechanisms: the role of Leishmania lipophosphoglycan on the human phagocyte functions. A review. Panaro MA; Panunzio M; Jirillo E; Marangi A; Brandonisio O Immunopharmacol Immunotoxicol; 1995 Aug; 17(3):595-605. PubMed ID: 8576549 [TBL] [Abstract][Full Text] [Related]
9. Mapping human T cell epitopes in leishmania gp63. Identification of cross-reactive and species-specific epitopes. Russo DM; Jardim A; Carvalho EM; Sleath PR; Armitage RJ; Olafson RW; Reed SG J Immunol; 1993 Feb; 150(3):932-9. PubMed ID: 7678627 [TBL] [Abstract][Full Text] [Related]
10. Does lipophosphoglycan enhance the T cell-stimulatory activity of lipophosphoglycan-associated proteins? Mendonça SC; De-Luca PM; Olafson RW; Jardim A; Coutinho SG Braz J Med Biol Res; 1994 Feb; 27(2):553-7. PubMed ID: 8081281 [TBL] [Abstract][Full Text] [Related]
11. Antigen-reactive gamma delta T cells in human leishmaniasis. Russo DM; Armitage RJ; Barral-Netto M; Barral A; Grabstein KH; Reed SG J Immunol; 1993 Oct; 151(7):3712-8. PubMed ID: 8376802 [TBL] [Abstract][Full Text] [Related]
12. Human T cell responses to gp63, a surface antigen of Leishmania. Russo DM; Burns JM; Carvalho EM; Armitage RJ; Grabstein KH; Button LL; McMaster WR; Reed SG J Immunol; 1991 Nov; 147(10):3575-80. PubMed ID: 1940356 [TBL] [Abstract][Full Text] [Related]
13. Effect of glycolipids of Leishmania parasites on human monocyte activity. Inhibition by lipophosphoglycan. Frankenburg S; Leibovici V; Mansbach N; Turco SJ; Rosen G J Immunol; 1990 Dec; 145(12):4284-9. PubMed ID: 2147940 [TBL] [Abstract][Full Text] [Related]
14. T-cell reactivity to purified lipophosphoglycan from Leishmania major: a model for analysis of the cellular immune response to microbial carbohydrates. Moll H; Röllinghoff M Behring Inst Mitt; 1991 Feb; (88):161-9. PubMed ID: 2049034 [TBL] [Abstract][Full Text] [Related]
15. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells. Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230 [TBL] [Abstract][Full Text] [Related]
16. Activation of human T lymphocytes by Leishmania lipophosphoglycan. Kemp M; Theander TG; Handman E; Hey AS; Kurtzhals JA; Hviid L; Sørensen AL; Were JO; Koech DK; Kharazmi A Scand J Immunol; 1991 Feb; 33(2):219-24. PubMed ID: 1902000 [TBL] [Abstract][Full Text] [Related]
17. Regulator and effector functions of T-cell subsets in human Leishmania infections. Kemp M APMIS Suppl; 1997; 68():1-33. PubMed ID: 9063493 [TBL] [Abstract][Full Text] [Related]
18. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile. Skeiky YA; Kennedy M; Kaufman D; Borges MM; Guderian JA; Scholler JK; Ovendale PJ; Picha KS; Morrissey PJ; Grabstein KH; Campos-Neto A; Reed SG J Immunol; 1998 Dec; 161(11):6171-9. PubMed ID: 9834103 [TBL] [Abstract][Full Text] [Related]
19. Distribution of lipophosphoglycan-associated epitopes in different Leishmania species and in African trypanosomes. Tolson DL; Schnur LF; Jardim A; Pearson TW Parasitol Res; 1994; 80(6):537-42. PubMed ID: 7528916 [TBL] [Abstract][Full Text] [Related]
20. Reversible defect in antigen-induced lymphokine and gamma-interferon generation in cutaneous leishmaniasis. Murray HW; Rubin BY; Carriero S; Acosta AM J Immunol; 1984 Oct; 133(4):2250-4. PubMed ID: 6432909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]